China
The Phase III clinical trial is a randomized, double-blind, placebo-controlled, multi-regional study designed to evaluate the efficacy and safety of 5mg (0...
March 29, 2023 | News
Discovered and developed in-house by Antengene's R&D team, ATG-022 is an antibody-drug-conjugate (ADC) targeting the Tumor Associated Antig...
March 29, 2023 | News
Boan Biotech (6955.HK) today announced its 2022 financial results and recent business developments. 2022 business highlights Record high in revenue: In...
March 28, 2023 | News
The joint venture will focus on genetic testing in the field of reproductive health and carry out in-depth collaboration on a series of projects that lever...
March 28, 2023 | News
"With the full upfront payment and other reimbursement from Gilead, we now have an even stronger balance sheet to advance development of products in our co...
March 28, 2023 | News
2022 Financial Highlights Revenue: The Group's revenue increased to RMB15,268.7 million with an increase of 48.4% y-o-y. The increase was...
March 23, 2023 | News
Jacobio Pharma (1167.HK) announced it has entered into a clinical collaboration with Merck & Co., Inc., Rahway, NJ, USA to evaluate the combinatio...
March 22, 2023 | News
The Agilis Robotics system is designed to make endoscopic and endoluminal surgery easier, faster, and more precise. The ultra-thin instruments ar...
March 20, 2023 | News
Stage 1 of ongoing 52-week China pivotal AD trial met primary and secondary endpoints No efficacy plateau at Week 16 In the study “CBP-201, a n...
March 20, 2023 | News
Development of Innovative and Differentiated Pipelines Core Product CM310 (IL-4Rα antibody): Initiated Phase III registrational cl...
March 18, 2023 | News
On December 22, 2022, Likang submitted an IND application for LK101 Injection to NMPA, and received application shortly after. LK101 Injection, the fi...
March 17, 2023 | News
ADC drugs have the advantages of highly specific targeting of antibody and anti cancer activity of cytotoxin. ADC shave developed rapidly as tumor therapeu...
March 16, 2023 | News
This is the first-ever global phase III trial for TGCT approved by NMPA and FDA. Pimicotinib (ABSK021)was granted BTD by FDA and CDE, discovered a...
March 16, 2023 | News
Ark Biopharmaceutical will lead development activities for AK0705 with the goal of initiating clinical studies in 2024. Calibr will continue to collabor...
March 16, 2023 | News
Most Read
Bio Jobs
News
Editor Picks